Position in NTRA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$8,218,963
+$3,014,424 QoQ
Shares Held
30,278
+16.3% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#220
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026IFM Investors Pty Ltd holds $135,318,167 across 11 Diagnostics & Research names. NTRA ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
84,397 | $42,313,279 | |
| 2 | DHR |
Danaher Corp /De/
|
148,671 | $28,318,852 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
19,244 | $10,130,811 | |
| 4 | A |
Agilent Technologies, Inc.
|
62,257 | $8,269,597 | |
| 5 | WAT |
Waters Corp /De/
|
21,933 | $8,225,752 | |
| 6 | NTRA |
Natera, Inc.
This page
|
30,278 | $8,218,963 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
38,182 | $7,377,526 | |
| 8 | ILMN |
Illumina, Inc.
|
33,001 | $5,802,565 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,218,963 | 30,278 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,204,539 | 26,024 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $5,758,177 | 25,135 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,953,584 | 24,561 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $4,147,139 | 24,548 | Shares | Sole | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||